Insighta
Insighta is a pioneering joint venture between Prenetics and acclaimed scientist Professor Dennis Lo, committed to transforming the landscape of multi-cancer early detection.
Powered by cutting-edge science from Prof. Lo, bolstered by $100 million in capital from Prenetics, and led by seasoned entrepreneur Danny Yeung, Insighta is at the forefront of innovation in cancer screening.
With a bold vision to reshape early diagnosis, Insighta is set to launch Presight for lung and liver cancers in 2025. Building on this momentum, the company plans to roll out Presight One—a groundbreaking platform capable of detecting 10+ cancers—by 2027. These innovations represent a monumental opportunity to improve patient outcomes, enhance accessibility to early detection, and make a significant impact in global cancer prevention.
Insighta not only aims to save lives but also strengthens Hong Kong’s reputation as a global hub for life sciences innovation, positioning the region at the forefront of the fight against cancer.
